Jonathan Leiken - 12 May 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP, CLO and Secretary
Signature: Jonathan B. Leiken
Issuer symbol: DBD
Transactions as of: 12 May 2022
Net transactions value: +$10,560
Form type: 4
Filing time: 12 May 2022, 10:32:32 UTC
Previous filing: 10 Mar 2022
Next filing: 01 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Purchase	$10,560	+4,400	+1.7%	$2.40^*	269,108	12 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option						21,397	12 May 2022	Common Shares	21,397	$32.33	Direct	F2
holding	DBD	Non-Qualified Stock Option						24,581	12 May 2022	Common Shares	24,581	$27.39	Direct	F2
holding	DBD	Non-Qualified Stock Options						46,875	12 May 2022	Common Shares	46,875	$26.60	Direct	F2
holding	DBD	Non-Qualified Stock Option						24,517	12 May 2022	Common Shares	24,517	$18.75	Direct	F3
holding	DBD	Non-Qualified Stock Option						43,715	12 May 2022	Common Shares	43,715	$4.08	Direct	F3
holding	DBD	Non-Qualified Stock Option						12,048	12 May 2022	Common Shares	12,048	$11.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Number includes restricted stock units.
F2	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.